EZCORP Announces Termination of Acquisition Agreement
AUSTIN, Texas, March 19, 2025 (GLOBE NEWSWIRE) -- EZCORP, Inc. (NASDAQ: EZPW) (the “Company”), a leading provider of pawn loans in the United States and Latin America, announced today that…
Emergent BioSolutions Finalizes Sale of Baltimore-Bayview Manufacturing Site to Syngene International
GAITHERSBURG, Md., March 19, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has completed the sale of its Baltimore-Bayview drug substance manufacturing facility to Syngene International.…
Paratek Pharmaceuticals to Acquire Optinose, Creating Significant Commercial Expansion Opportunities for XHANCE® in Chronic Rhinosinusitis (CRS)
Paratek will accelerate access for XHANCE beyond specialists to primary care providers maximizing the recent label expansion for CRS in a ~10‑million‑patient marketAcquisition advances Paratek’s vision to become a multi-product…
Arcadis acquires WSP Infrastructure Engineering GmbH, strengthening its position in the attractive German rail market
Arcadis acquires WSP Infrastructure Engineering GmbH, strengthening its position in the attractive German rail market Amsterdam, 20 March 2025 – Arcadis, a global leader in intelligence-driven sustainable design, engineering, and…
Alvotech Acquires Xbrane’s R&D Operations in Sweden and Further Affirms its Global Leadership Position in Biosimilars Development and Production
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the acquisition of Xbrane Biopharma AB’s (“Xbrane”) R&D operations…
Notification of transaction by a closely associated person of a Director of Millicom (Tigo)
Notification of transaction by a closely associated person of a Director of Millicom (Tigo) Luxembourg, March 17, 2025 – Millicom International Cellular S.A. ("Millicom") announces that, on March 14, 2025,…
Alvotech kaupir þróunarstarfsemi líftæknifyrirtækisins Xbrane í Svíþjóð
Alvotech (NASDAQ: ALVO) tilkynnti í dag að fyrirtækið hafi keypt þróunarstarfsemi sænska líftæknifyrirtækisins Xbrane Biopharma AB (“Xbrane”). Með kaupunum eykur Alvotech afkastagetu sína í þróun nýrra líftæknilyfjahliðstæða, styrkir stöðu sína…
Dundee Precious Adopts Shareholder Rights Plan
TORONTO, March 17, 2025 (GLOBE NEWSWIRE) -- Dundee Precious Metals (“DPM” or the “Company”) announces that its Board of Directors (the “Board”) has approved the adoption of a Shareholder Rights…
Nioko Resources Files Early Warning Report in Respect of Orezone Gold Corporation
OUAGADOUGOU, Burkina Faso, March 17, 2025 (GLOBE NEWSWIRE) -- This news release is issued by Nioko Resources Corporations (“Nioko Resources”) pursuant to the early warning requirements of Canada’s National Instrument…
Alvotech Acquires Xbrane’s R&D Operations in Sweden and Further Affirms its Global Leadership Position in Biosimilars Development and Production
REYKJAVIK, Iceland and STOCKHOLM, March 20, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today…